The diabetes mellitus codes are combination codes that include the type of diabetes mellitus, the body system affected, and the complications affecting that body system. As many codes within a particular category as are necessary to describe all of the complications of the disease may be used. They should be sequenced based on the reason for a particular encounter. Assign as many codes from categories E08 – E13 as needed to identify all of the associated conditions that the patient has.
E74.89
BookmarkOther specified disorders of carbohydrate metabolism
Filed alongside this entry 305
under Disorder (of)
- acantholytic L11.9
- adjustment (grief) F43.20
- adrenal (capsule) (gland) (medullary) E27.9
- adrenogenital E25.9
- adult personality (and behavior) F69
- aggressive, unsocialized F91.1
- alcohol-related F10.99
- alveolar NEC J84.09
- anaerobic glycolysis with anemia D55.29
- anxiety F41.9
- aromatic amino-acid metabolism E70.9
- arteriole NEC I77.89
- artery NEC I77.89
- attention-deficit hyperactivity (adolescent) (adult) (child) F90.9
- attention-deficit without hyperactivity (adolescent) (adult) (child) F98.8
- auditory processing (central) H93.25
- autistic F84.0
- autism spectrum F84.0
- autoimmune D89.89
- autonomic nervous system G90.9
- bereavement, persistent complex F43.81
- beta-amino-acid metabolism E72.89
- bile acid and cholesterol metabolism E78.70
- bilirubin excretion E80.6
- binge eating F50.81
- bipolar (I) (seasonal) (type 1) F31.9
- bladder N32.9
- bleeding D68.9
- blood D75.9
- body dysmorphic F45.22
- bone M89.9
- brachial plexus G54.0
- branched-chain amino-acid metabolism E71.2
- breast N64.9
- Briquet's F45.0
- bullous, in diseases classified elsewhere L14
- cardiac, functional I51.89
- carnitine metabolism E71.40
- cartilage M94.9
- catatonia (due to known physiological condition) (with another mental disorder) F06.1
- catatonic NOS F06.1
- central auditory processing H93.25
- character NOS F60.9
- childhood disintegrative NEC F84.3
- cholesterol and bile acid metabolism E78.70
- choroid H31.9
- citrate metabolism NEC E74.829
- citrate transporter, SLC13A5 E74.820
- coagulation (factor) D68.9
- coccyx NEC M53.3
- cognitive F09
- communication F80.9
- conduct (childhood) F91.9
- conduction, heart I45.9
- congenital glycosylation (CDG) E74.89
- conjunctiva H11.9
- connective tissue, localized L94.9
- cornea H18.9
- corpus cavernosum N48.9
- Cyclin-Dependent Kinase-Like 5 Deficiency (CDKL5) G40.42
- cyclothymic F34.0
- defiant oppositional F91.3
- delusional (persistent) (systematized) F22
- depersonalization F48.1
- depressive F32.A
- developmental F89
- diaphragm J98.6
- digestive (system) K92.9
- disc (intervertebral) M51.9
- disinhibited attachment (childhood) F94.2
- disintegrative, childhood NEC F84.3
- disruptive F91.9
- dissocial personality F60.2
- dissociative F44.9
- dream anxiety F51.5
- drug induced hemorrhagic D68.32
- drug related F19.99
- dysmorphic body F45.22
- dysthymic F34.1
- ear H93.9
- eating (adult) (psychogenic) F50.9
- electrolyte (balance) NEC E87.8
- elimination, transepidermal L87.9
- emotional (persistent) F34.9
- endocrine E34.9
- erectile (male) (organic) N52.9
- esophagus K22.9
- eustachian tube H69.9
- exhibitionistic F65.2
- extrapyramidal G25.9
- eye H57.9
- eyelid H02.9
- feeding (infant or child) R63.30
- feigned (with obvious motivation) Z76.5
- fetishistic F65.0
- fibroblastic M72.9
- fluid balance E87.8
- follicular (skin) L73.9
- FOXG1-related QA0.0151
- frotteuristic F65.81
- fructose metabolism E74.10
- functional polymorphonuclear neutrophils D71.9
- gallbladder, biliary tract and pancreas in diseases classified elsewhere K87
- gambling F63.0
- gamma aminobutyric acid (GABA) metabolism E72.81
- gamma-glutamyl cycle E72.89
- gastric (functional) K31.9
- gastrointestinal (functional) NOS K92.9
- gender incongruence F64.9
- gender-identity or -role F64.9
- genito-pelvic pain penetration F52.6
- globe H44.9
- glomerular (in) N05.9
- gluconeogenesis E74.4
- glucose transport E74.819
- glycine metabolism E72.50
- glycoprotein metabolism E77.9
- habit (and impulse) F63.9
- heart action I49.9
- hematological D75.9
- hematopoietic organs D75.9
- hemorrhagic NEC D69.9
- histidine metabolism E70.40
- hoarding F42.3
- hyperleucine-isoleucinemia E71.19
- hypervalinemia E71.19
- hypoactive sexual desire F52.0
- hypochondriacal F45.20
- immune mechanism (immunity) D89.9
- impaired renal tubular function N25.9
- impulse (control) F63.9
- integument, newborn P83.9
- intermittent explosive F63.81
- involuntary emotional expression (IEED) F48.2
- iris H21.9
- iron metabolism E83.10
- isovaleric acidemia E71.110
- jaw, developmental M27.0
- joint M25.9
- ketone metabolism E71.32
- kidney N28.9
- lacrimal system H04.9
- lactation NEC O92.79
- language (developmental) F80.9
- late luteal phase dysphoric N94.89
- learning (specific) F81.9
- lens H27.9
- ligament M24.20
- liver K76.9
- lung, interstitial, drug-induced J70.4
- lymphoproliferative, post-transplant (PTLD) D47.Z1
- lysine and hydroxylysine metabolism E72.3
- major neurocognitive F03
- manic F30.9
- meninges, specified type NEC G96.198
- menopausal N95.9
- menstrual N92.6
- mental (or behavioral) (nonpsychotic) F99
- metabolic, amino acid, transitory, newborn P74.8
- metabolism NOS E88.9
- methylmalonic acidemia E71.120
- micturition NEC R39.198
- mild neurocognitive G31.84
- mitochondrial metabolism E88.40
- mood F39
- movement G25.9
- multiple personality F44.81
- muscle M62.9
- myoneural G70.9
- myotonic NEC G71.19
- nail, in diseases classified elsewhere L62
- neonatal onset multisystemic inflammatory (NOMID) M04.2
- nerve G58.9
- nervous system G98.8
- neurocognitive R41.9
- neurodevelopmental F89
- neurohypophysis NEC E23.3
- neurological NEC R29.818
- neuromuscular G70.9
- neurotic F48.9
- neutrophil, polymorphonuclear D71.9
- nightmare F51.5
- nose J34.9
- obsessive-compulsive F42.9
- odontogenesis NOS K00.9
- oppositional defiant F91.3
- orbit H05.9
- orgasmic (female) F52.31
- ornithine metabolism E72.4
- overanxious F41.1
- pancreatic internal secretion E16.9
- panic F41.0
- papulosquamous L44.9
- paranoid F22
- paraphilic F65.9
- parathyroid (gland) E21.5
- parietoalveolar NEC J84.09
- paroxysmal, mixed R56.9
- patella M22.9
- patellofemoral M22.2X
- pedophilic F65.4
- pentose phosphate pathway with anemia D55.1
- perception, due to hallucinogens F16.983
- peripheral nervous system NEC G64
- peroxisomal E71.50
- personality F60.9
- pervasive, developmental F84.9
- phobic anxiety, childhood F40.8
- phosphate-losing tubular N25.0
- pigmentation L81.9
- pinna (noninfective) H61.10
- pituitary gland E23.7
- platelet-activating anti-PF4, specified NEC D75.84
- platelets D69.19
- plexus G54.9
- polymorphonuclear neutrophils D71.9
- postconcussional F07.81
- posthallucinogen perception F16.983
- postmenopausal N95.9
- post-transplant lymphoproliferative D47.Z1
- post-traumatic stress (PTSD) F43.10
- premenstrual dysphoric (PMDD) F32.81
- prepuce N47.8
- propionic acidemia E71.121
- prostate N42.9
- psychogenic NOS F45.9
- psychological F99
- psychomotor NEC F44.4
- psychosexual F65.9
- puberty E30.9
- purine metabolism E79.9
- pyrimidine metabolism E79.9
- pyruvate metabolism E74.4
- reactive attachment (childhood) F94.1
- reading R48.0
- receptive language F80.2
- receptor, hormonal, peripheral E34.50
- recurrent brief depressive F33.8
- reflex R29.2
- refraction H52.7
- relationship F68.8
- REM sleep behavior G47.52
- renal function, impaired (tubular) N25.9
- resonance R49.9
- retina H35.9
- retroperitoneal K68.9
- right hemisphere organic affective F07.89
- rumination (infant or child) (in remission) F98.21
- sacrum, sacrococcygeal NEC M53.3
- schizoaffective F25.9
- schizoid of childhood F84.5
- schizophrenia spectrum and other psychotic disorder F29
- schizophreniform F20.81
- schizotypal (personality) F21
- secretion, thyrocalcitonin E07.0
- seizure G40.909
- semantic pragmatic F80.89
- sense of smell R43.1
- separation anxiety, of childhood F93.0
- shyness, of childhood and adolescence F40.10
- sibling rivalry F93.8
- sinus (nasal) J34.9
- skin L98.9
- SLC13A5 Citrate Transporter Disorder E74.820
- sleep G47.9
- sleep-wake pattern or schedule G47.9
- soft tissue M79.9
- somatic symptom F45.1
- somatization F45.0
- somatoform F45.9
- speech R47.9
- speech-sound F80.0
- spelling (specific) F81.81
- stereotyped, habit or movement F98.4
- stress F43.9
- sulfur-bearing amino-acid metabolism E72.10
- sweat gland (eccrine) L74.9
- synovium M67.90
- temperature regulation, newborn P81.9
- temporomandibular joint M26.60
- tendon M67.90
- thoracic root (nerve) NEC G54.3
- thyrocalcitonin hypersecretion E07.0
- thyroid (gland) E07.9
- tooth K08.9
- Tourette's F95.2
- trance and possession F44.89
- transvestic F65.1
- trauma and stressor-related NOS F43.9
- tryptophan metabolism E70.5
- tubular, phosphate-losing N25.0
- tubulo-renal function, impaired N25.9
- tympanic membrane H73.9
- unsocialized aggressive F91.1
- urea cycle metabolism E72.20
- ureter (in) N28.9
- urethra N36.9
- urinary system N39.9
- vestibular function H81.9
- vision, binocular H53.30
- vitreous body H43.9
- voice R49.9
- voyeuristic F65.3
- white blood cells D72.9
- withdrawing, child or adolescent F40.10
Index entries, exactly as the book files them. This says they are listed together — not that any of them is documented in your chart.
How to use this page
Everything the published sources say about one code, on one page.
- Read the Excludes1 block first — it is the one that stops you coding this at all alongside another code.
- Excludes2, Code first, Use additional and Includes follow. A note inherited from a parent category is labelled with the category it came from, so you can see why it applies.
- Official Guidelines sit below. "Guidelines naming this code" cite the code or a range containing it; "Chapter guidance" is the general guidance for its chapter and is the weaker signal.
- Guideline text is quoted verbatim with its section number and page, so you can check it against the published document.
- Risk-model chips show which published CMS models map this code.
What this page does not do
- Guidance is quoted, never paraphrased — a paraphrase of a coding rule is a different rule.
- Medication candidates, where shown, are matched by condition *name* and are offered as candidates for you to judge. They are not "the drugs for this code".
Exclusions11never code together
- diabetes mellitus (E08-E13)E08-E13
- hypoglycemia NOS (E16.2)E16.2
- increased secretion of glucagon (E16.3)E16.3
- mucopolysaccharidosis (E76.0-E76.3)E76.0-E76.3
- transitory endocrine and metabolic disorders specific to newborn (P70-P74)P70-P74
Excludes1 — never code together. The excluded condition and this one are mutually exclusive.
Excludes2 — not included here, but the patient may have both. Code both when documented.
Instructional notes2
- Essential pentosuria
- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.E05.8E07.0E16-E31E34.-
Official Guidelines16
ICD-10-CM Official Guidelines for Coding and Reporting, quoted in full. Published by CMS and NCHS; in the public domain.
The age of a patient is not the sole determining factor, though most type 1 diabetics develop the condition before reaching puberty. For this reason, type 1 diabetes mellitus is also referred to as juvenile diabetes.
Codes E10.A-, Type 1 diabetes mellitus, presymptomatic, are assigned for early-stage type 1 diabetes that predates the onset of symptoms.
Code E11.A, Type 2 diabetes mellitus without complications in remission, is assigned based on provider documentation that the diabetes mellitus is in remission. If the documentation is unclear as to whether the Type 2 diabetes mellitus has achieved remission, the provider should be queried. For example, the term “resolved” is not synonymous with remission.
If the type of diabetes mellitus is not documented in the medical record the default is E11.-, Type 2 diabetes mellitus.
If the documentation in a medical record does not indicate the type of diabetes but does indicate that the patient uses insulin, code E11-, Type 2 diabetes mellitus, should be assigned. Additional code(s) should be assigned from category Z79 to identify the long-term (current) use of insulin, oral hypoglycemic drugs, or injectable non-insulin antidiabetic, as follows: If the patient is treated with both oral hypoglycemic drugs and insulin, both code Z79.4, Long term (current) use of insulin, and code Z79.84, Long term (current) use of oral hypoglycemic drugs, should be assigned. If the patient is treated with both insulin and an injectable non-insulin antidiabetic drug, assign codes Z79.4, Long term (current) use of insulin, and Z79.85, Long-term (current) use of injectable non-insulin antidiabetic drugs. If the patient is treated with both oral hypoglycemic drugs and an injectable non-insulin antidiabetic drug, assign codes Z79.84, Long term (current) use of oral hypoglycemic drugs, and Z79.85, Long-term (current) use of injectable non-insulin antidiabetic drugs. Code Z79.4 should not be assigned if insulin is given temporarily to bring a type 2 patient’s blood sugar under control during an encounter.
See Section I.C.15. Diabetes mellitus in pregnancy. See Section I.C.15. Gestational (pregnancy induced) diabetes
An underdose of insulin due to an insulin pump failure should be assigned to a code from subcategory T85.6, Mechanical complication of other specified internal and external prosthetic devices, implants and grafts, that specifies the type of pump malfunction, as the principal or first-listed code, followed by code T38.3X6-, Underdosing of insulin and oral hypoglycemic [antidiabetic] drugs. Additional codes for the type of diabetes mellitus and any associated complications due to the underdosing should also be assigned.
The principal or first-listed code for an encounter due to an insulin pump malfunction resulting in an overdose of insulin, should also be T85.6-, Mechanical complication of other specified internal and external prosthetic devices, implants and grafts, followed by code T38.3X1-, Poisoning by insulin and oral hypoglycemic [antidiabetic] drugs, accidental (unintentional).
Codes under categories E08, Diabetes mellitus due to underlying condition, E09, Drug or chemical induced diabetes mellitus, and E13, Other specified diabetes mellitus, identify complications/manifestations associated with secondary diabetes mellitus. Secondary diabetes is always caused by another condition or event (e.g., cystic fibrosis, malignant neoplasm of pancreas, pancreatectomy, adverse effect of drug, or poisoning).
hypoglycemic drugs, or injectable non-insulin drugs For patients with secondary diabetes mellitus who routinely use insulin, oral hypoglycemic drugs, or injectable non-insulin drugs, additional code(s) from category Z79 should be assigned to identify the long-term (current) use of insulin, oral hypoglycemic drugs, or non-injectable non-insulin drugs as follows: If the patient is treated with both oral hypoglycemic drugs and insulin, both code Z79.4, Long term (current) use of insulin, and code Z79.84, Long term (current) use of oral hypoglycemic drugs, should be assigned. If the patient is treated with both insulin and an injectable non- insulin antidiabetic drug, assign codes Z79.4, Long- term (current) use of insulin, and Z79.85, Long-term (current) use of injectable non-insulin antidiabetic drugs. If the patient is treated with both oral hypoglycemic drugs and an injectable non-insulin antidiabetic drug, assign codes Z79.84, Long-term (current) use of oral hypoglycemic drugs, and Z79.85, Long-term (current) use of injectable non-insulin antidiabetic drugs. Code Z79.4 should not be assigned if insulin is given temporarily to bring a secondary diabetic patient’s blood sugar under control during an encounter.
causes The sequencing of the secondary diabetes codes in relationship to codes for the cause of the diabetes is based on the Tabular List instructions for categories E08, E09 and E13.
For postpancreatectomy diabetes mellitus (lack of insulin due to the surgical removal of all or part of the pancreas), assign code E89.1, Postprocedural hypoinsulinemia. Assign a code from category E13 as the principal or first- listed diagnosis and a code from subcategory Z90.41, Acquired absence of pancreas, as an additional code.
Secondary diabetes may be caused by an adverse effect of correctly administered medications, poisoning or sequela of poisoning. See section I.C.19.e. for coding of adverse effects and poisoning, and section I.C.20 for external cause code reporting.
The obesity codes in category E66, Overweight and obesity, include codes related to the cause of obesity, such as drug-induced obesity (E66.1), and codes related to effects of obesity, such as code E66.2, Morbid (severe) obesity with alveolar hypoventilation. There are other codes related to obesity in other categories of the classification, such as E88.82, Obesity due to disruption of MC4R pathway; and codes in fifth character subcategory O99.21, Obesity complicating pregnancy, childbirth, and the puerperium.
The obesity class codes in subcategory E66.81, Obesity class, require a fifth character to convey the severity of obesity. The obesity class should be documented in the medical record by the provider for these codes to be assigned. The obesity class codes can be reported with other obesity codes in the classification found in Chapters 4 and 15 to fully describe the condition. However, if both class 3 obesity and morbid obesity are documented, only a code for class 3 obesity should be assigned as it is more specific.
Index entries leading here2
Alongside this code2same parent — E74.8
Additional references
Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.